These include patients who prefer moderate-intensity therapy and patients who cannot tolerate high-intensity therapy.According to the new guidelines, moderate-intensity therapy is acceptable for patients with diabetes aged 40 to 75 with LDL levels between 70 mg/dL and 189 mg/dL who do not have clinical ASCVD and whose 10-year risk of ASCVD is lower than 7.5%.